Search...
Features
Assets
Blog
Help
Learn
Get App
Login
Sign Up
Get App
Arrowhead Pharmaceuticals (ARWR) Q4 2022 Earnings
ARWR
+3.85%
28
Nov
Confirmed
Q1 2022
Q2 2022
Q3 2022
Q4 2022
-0.81
-0.4
0
0.41
Details
Expected EPS
-0.29
Actual EPS
-0.81
Surprise EPS
-0.52
Surprise Percent
+179.31%
Description
Arrowhead Pharmaceuticals (ARWR) has reported earnings of -0.81 per share for Q4 2022.
0 Comments
Share your thoughts
Get the Stock Events App
Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.
Sign Up
Login